Skip Navigation

Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH)

printer friendly version


A 5-year longitudinal observational study of patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis (TARGET-NASH)

 

Enrollment status: OPEN

 

Objective

The goal of this research study is to observe any treatment for NAFLD/NASH in a large number of people in a "real-life" setting. Researchers are interested in observing how lifestyle changes, counseling, or other treatments work in patients who are treated by their doctors in routine practice.

Inclusion criteria

Exclusion criteria

Study design

Contacts for referrals and questions:

Principal investigator: Anna Lok, MD aslok@med.umich.edu


University of Michigan–Peking University Joint Initiative

 

Role of visceral adiposity in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) in lean versus obese patients: A comparative study between patients at University of Michigan Health System versus Peking University Health Science Center

 

Enrollment status: Actively enrolling

 

Objective

To use a novel technique, analytic morphomics, to quantify visceral adipose tissue, ectopic adipose tissue and quality of fat in lean persons with NAFLD versus lean persons with no NAFLD and obese persons with NAFLD to understand why some lean persons develop fatty liver and to understand the role of fat in the abdomen on development of fatty liver.

**Control patients also needed with body mass index <25, no diabetes, and no liver disease**

Inclusion criteria

Exclusion criteria

Study design

Contacts for referrals and questions:

Principal investigator: Anna Lok, MD aslok@med.umich.edu